Ignite Creation Date:
2024-05-06 @ 4:03 PM
Last Modification Date:
2024-10-26 @ 2:03 PM
Study NCT ID:
NCT04858334
Status:
RECRUITING
Last Update Posted:
2024-07-15
First Post:
2021-04-23
Brief Title:
APOLLO A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1 BRCA2 or PALB2 Mutation
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-06-22
Start Date Type:
ACTUAL
Primary Completion Date:
2027-10-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-10-31
Completion Date Type:
ESTIMATED
First Submit Date:
2021-04-23
First Submit QC Date:
April 23 2021
Study First Post Date:
2021-04-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-22
Last Update Post Date:
2024-07-15
Last Update Post Date Type:
ESTIMATED